SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000906344-07-000168
Filing Date
2007-02-13
Accepted
2007-02-12 18:04:03
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G RE BIOCRYST PHARMACEUTICALS, INC. 02-12-2007 biocr13g.txt SC 13G 14763
  Complete submission text file 0000906344-07-000168.txt   16476
Mailing Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244
Business Address 2190 PARKWAY LAKE DR BIRMINGHAM AL 35244 2054444600
BIOCRYST PHARMACEUTICALS INC (Subject) CIK: 0000882796 (see all company filings)

IRS No.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-44055 | Film No.: 07604849
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address ONE SANSOME STREET, SUITE 2900 SAN FRANCISCO CA 94104
Business Address 415.835.3818
STEPHENS WILLIAM BRADFORD (Filed by) CIK: 0001366498 (see all company filings)

Type: SC 13G